CUPERTINO, Calif., Oct. 7, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has completed enrollment in its Phase 2a clinical trial of topical DUR-928 in p

LOS ANGELES, Oct. 7, 2019 /PRNewswire/ -- The American Cancer Society (ACS) is teaming up with celebrity ambassadors this month to encourage their families, friends, fans and followers alike to "Get #YOUnited" in the fight against breast cancer by purchasing celebrity designed merchandise and giving donations. With this new campaign, ACS has engaged notable pop culture f

NEW BRUNSWICK, N.J., Oct. 7, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ), the world's largest and most broadly-based healthcare company, today published

SOUTH PLAINFIELD, N.J., Oct. 7, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a collaboration with Aldevron, LLC to secure GMP manufacturing capacity for PTC's gene therapy portfolio, including the Friedreich ataxia and Angelman syndrome programs in PTC's growing gene therapy pipeline.   "Our strategic collaboration with Alde

BOSTON, Oct. 7, 2019 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of no

NEW YORK, Oct. 7, 2019 /PRNewswire/ -- Equity research is published in the framework of Frost's Independent Equity Research Program. This type of equity research is trusted by investors as it is unbiased and analysts have no financial interest in the stock. You can explore all of the companies we cover

TEL AVIV, Israel, Oct. 7, 2019 /PRNewswire/ -- Vascular Graft Solutions reports the presentation of Clinical data from two prospective trials of the VEST external stent for vein grafts during CABG which was presented at the 2019 European Cardio-Thoracic Surgery (

ATLANTA, Oct. 7, 2019 /PRNewswire/ -- Surterra Wellness today announced that it has changed its corporate name to Parallel™ effective today. Parallel, formerly Surterra Wellness, is a leading, global company that is pioneering human well-being through its proprietary cannabinoid brands and science- and technology-led innovation.

BRIDGEWATER, N.J., Oct. 7, 2019 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced that 14 new scientific poster and clinical presentations involving the company's products, as well as data from the company's Antibiotic Resistance Monitoring in Ocular MicRoorganis

PURCHASE, N.Y., Oct. 7, 2019 /PRNewswire/ -- Westmed Medical Group, an award-winning multispecialty medical practice based in Purchase, NY, announced to